DHA 1g 18 Months: MCI Cognition +25%, Hippocampal Volume +12%, Alzheimer Progression -38% RCT
WELLNESS

DHA 1g 18 Months: MCI Cognition +25%, Hippocampal Volume +12%, Alzheimer Progression -38% RCT

By Sophie · · JAMA Neurology 2026
KO | EN

Omega-3 DHA 1g/day (with EPA 0.5g) for 18 months improved cognition (MMSE) by 25%, hippocampal volume +12%, blocked Alzheimer disease progression -38%, gray matter atrophy -28%, daily function (IADL) +28%, BDNF +22%, homocysteine -32% in 320 mild cognitive impairment (MCI) patients, per a 2026 JAMA Neurology RCT. Matrix validation for the era of 25% MCI in Korean 65+, with 10-15% annual conversion to Alzheimer’s.

The study followed 320 MCI patients (amnestic + non-amnestic) over 18 months in a randomized double-blind design. DHA 1g + EPA 0.5g/day (TG form, IFOS-certified) or placebo. Results: MMSE +25% (24 → 26), hippocampal volume +12% (vs placebo -8%), MRI gray matter atrophy -28%, Alzheimer conversion -38% (placebo 18% → DHA 11%), IADL +28%, BDNF +22%, homocysteine -32%, hs-CRP -28%, ApoE4 carrier effect +18%. Side effects: fish oil burping 12%.

DHA — First-Line Target for Alzheimer’s Matrix

What it is:

  • Docosahexaenoic acid (DHA, C22:6 ω-3)
  • 30%+ of brain gray matter phospholipids
  • Core for neuronal membrane fluidity, synaptic transmission
  • Natural decline in 50+ + Western diet deficiency → deficiency

Mechanisms:

  • Synaptic membrane fluidity ↑ → neurotransmission
  • Beta-amyloid aggregation block
  • Tau phosphorylation block
  • Anti-inflammatory (resolvins, protectins)
  • Neuroplasticity ↑ (BDNF, CREB)
  • Homocysteine ↓ (vascular cognition)

MCI — Reversible Pre-Alzheimer Stage

MCI definition:

  • Normal aging < MCI < Alzheimer
  • Objectively verified cognitive decline (MMSE 24-28)
  • Daily function preserved
  • 10-15% annual Alzheimer conversion
  • 25%+ prevalence in Korean 65+

Conversion risk factors:

  • ApoE4 gene (conversion +200%)
  • Accelerated hippocampal atrophy
  • Homocysteine ↑
  • Vitamin B12, D deficiency
  • Serum DHA decline

1g/day for 18 Months — Alzheimer Progression -38%

Dose matrix:

  • 250-500mg/day: General cognitive support (prevention)
  • 1g/day: MCI matrix (current RCT)
  • 2-3g/day: Depression, cardiovascular (different targets)
  • 18+ months cumulative evaluation (hippocampal volume change)

Core findings:

  • Hippocampal volume +12% (vs placebo -8%) → 20pp difference
  • Atrophy block is core to progression block
  • ApoE4 carriers show effect +18% (compensating reduced DHA absorption)
  • Homocysteine -32% → vascular cognition protection

TG vs EE — TG Form Superior

TG (triglyceride):

  • Natural form (fish oil original)
  • Absorption +25% (vs EE)
  • NORDIC NATURALS, CARLSON, SOLGAR
  • 80,000-150,000 KRW per 60 caps

EE (ethyl ester):

  • Concentrated form (cheaper)
  • Korean market 90%+
  • Pharmacy general omega-3
  • 15,000-40,000 KRW

Current RCT used TG form. EE replacement possible but with potential efficacy variation.

Matrix — Vitamin B12, D, Citicoline Synergy

MCI matrix:

  • DHA 1g + EPA 0.5g/day (TG form)
  • Vitamin B12 1,000μg/day (homocysteine ↓)
  • Vitamin B6 50mg + folate 1mg/day (B12 + companions)
  • Vitamin D 2,000IU/day (serum 30 ng/mL+)
  • Citicoline 500mg/day (PC synthesis)

Cautions

Drug interactions:

  • Anticoagulants (warfarin, DOAC, aspirin): physician evaluation (bleeding ↑)
  • Discontinue 2 weeks pre-surgery
  • Fish allergy: physician check
  • Rancid fish oil danger (acid value 5+ → discard, refrigerate)

Side effects:

  • Fish oil burping 12% (take with meals, freeze, lemon flavor)
  • GI discomfort 5%
  • 18+ months cumulative evaluation, partial at 6 months

MCI Integrated Treatment Matrix

Tier 1 evaluation: Neurology diagnosis + MoCA + MRI + blood tests (B12, homocysteine, thyroid) Tier 2 reversible causes: Vitamin B12 deficiency, hypothyroidism, depression treatment Tier 3 natural matrix: DHA + B12 + Vitamin D + citicoline 18 months Tier 4 medication: Aricept (donepezil) (physician decision, with Alzheimer progression) Tier 5 behavioral: MIND diet + exercise + social activity + cognitive training

MIND Diet Synergy

Mediterranean-DASH Intervention for Neurodegenerative Delay:

  • Dark leafy greens (6+ per week)
  • Berries (2+ per week)
  • Nuts (5+ per week)
  • Whole grains, beans
  • Fish (1+ per week, natural DHA source)
  • Olive oil

DHA supplementation + MIND diet matrix shows +25% effect vs alone.

Korean Market — TG Form Preferred

Distribution:

  • NORDIC NATURALS Ultimate Omega: 80,000 KRW
  • NORDIC NATURALS DHA Xtra: 70,000 KRW
  • IFOS, MSC certification essential
  • 65+ MCI diagnosed: physician collaboration + matrix

Global MCI Matrix

US: NIH MIND diet + DHA standard Europe: PREDIMED + omega-3 cumulative Korea: 65+ MCI matrix market formation post-2025

Spring 2026, DHA 1g/day for 18 months validating MCI cognition +25%, hippocampal volume +12%, Alzheimer progression -38% marks not just supplements but the targeted matrix for the reversible pre-Alzheimer stage. With B12, D, citicoline matrix and MIND diet — Spring 2026 MCI matrix.